In elderly subjects that developed influenza, IFNγ levels were 10-fold lower from A/H3N2-stimulated PBMCs, and this was a better correlate of poor protection from the subsequent 2003–04 trivalent influenza vaccine than antibody titre [58]. The gene discussed is IFNG; the disease is influenza.